Literature DB >> 15931343

Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.

Nicole M Parrish1, Chiew G Ko, James D Dick, Paul B Jones, Jay L E Ellingson.   

Abstract

OBJECTIVE: Mycobacterium avium subspecies (subsp.) paratuberculosis (MAP) is the causative agent of Johne's disease in ruminants and has been associated with Crohn's disease in humans. We sought to test growth rates and susceptibilities of various strains of MAP in two available growth media.
DESIGN: Paired comparison design.
METHODS: Using the BACTEC macrobroth radiometric growth system and Congo Red-staining agar media, we determined inherent differences in growth characteristics of three bovine and two human strains of MAP and compared susceptibility results obtained in each growth system.
RESULTS: Significant differences were observed in growth rate as well as mycobactin J dependence between strains and between a laboratory-adapted isolate of the same strain in the macrobroth system. Similarly, colonial morphology and Congo Red staining on agar media were observed. Two strains, one human and one bovine, demonstrated a 100% rough transparent colony with white coloration on Congo Red agar, while one bovine isolate exclusively grew as a smooth opaque colony with red coloration on Congo Red agar. The remaining strains exhibited mixtures of these two colonial morphotypes on agar media. Comparative susceptibility results between the BACTEC radiometric macrobroth method and the agar proportionality method showed good correlation for most antibiotics/inhibitors tested. However, erratic or poor growth in the macrobroth system prevented minimal inhibitory concentration determinations for two bovine strains by this method.
CONCLUSION: This study demonstrates the variability in the colonial morphology of MAP on Congo Red agar as well as the correlation of antibiotic susceptibility results between the BACTEC macro broth method and the agar proportionality method. This study also emphasizes the need for the development of improved, standardized culture and susceptibility test methods for MAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15931343      PMCID: PMC1069079          DOI: 10.3121/cmr.2.2.107

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  42 in total

1.  Mycobacterium paratuberculosis DNA in Crohn's disease tissue.

Authors:  J D Sanderson; M T Moss; M L Tizard; J Hermon-Taylor
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Mycobacterium paratuberculosis. Factors that influence mycobactin dependence.

Authors:  R S Lambrecht; M T Collins
Journal:  Diagn Microbiol Infect Dis       Date:  1992 Mar-Apr       Impact factor: 2.803

3.  Absence of Mycobacterium paratuberculosis DNA in intestinal tissues from Crohn's disease by nested polymerase chain reaction.

Authors:  K Kanazawa; Y Haga; O Funakoshi; H Nakajima; A Munakata; Y Yoshida
Journal:  J Gastroenterol       Date:  1999-04       Impact factor: 7.527

4.  Isolation and analysis of restriction endonuclease digestive patterns of chromosomal DNA from Mycobacterium paratuberculosis and other Mycobacterium species.

Authors:  D L Whipple; R B Le Febvre; R E Andrews; A B Thiermann
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Effects of colonial morphology and tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis.

Authors:  R M Van Boxtel; R S Lambrecht; M T Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

6.  Colony morphotypes on Congo red agar segregate along species and drug susceptibility lines in the Mycobacterium avium-intracellulare complex.

Authors:  G A Cangelosi; C O Palermo; J P Laurent; A M Hamlin; W H Brabant
Journal:  Microbiology       Date:  1999-06       Impact factor: 2.777

7.  Specific detection of Mycobacterium paratuberculosis by DNA hybridisation with a fragment of the insertion element IS900.

Authors:  M T Moss; E P Green; M L Tizard; Z P Malik; J Hermon-Taylor
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

8.  Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.

Authors:  D M Yajko; P S Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

9.  Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol.

Authors:  N Rastogi; K S Goh; V Labrousse
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Characterization of clinical isolates of Mycobacterium paratuberculosis by DNA-DNA hybridization and cellular fatty acid analysis.

Authors:  F Saxegaard; I Baess; E Jantzen
Journal:  APMIS       Date:  1988-06       Impact factor: 3.205

View more
  9 in total

1.  Analysis of the contribution of MTP and the predicted Flp pilus genes to Mycobacterium tuberculosis pathogenesis.

Authors:  Katherine M Mann; Aaron C Pride; Kelly Flentie; Jacqueline M Kimmey; Leslie A Weiss; Christina L Stallings
Journal:  Microbiology (Reading)       Date:  2016-08-31       Impact factor: 2.777

2.  Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.

Authors:  Stella Y Y Wong; Irene R Grant; Mendel Friedman; Christopher T Elliott; Chen Situ
Journal:  Appl Environ Microbiol       Date:  2008-08-01       Impact factor: 4.792

3.  Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.

Authors:  Sung Jae Shin; Michael T Collins
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

4.  Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatis.

Authors:  Kriti Arora; Danelle C Whiteford; Dalia Lau-Bonilla; Christine M Davitt; John L Dahl
Journal:  J Bacteriol       Date:  2008-04-11       Impact factor: 3.490

5.  "In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.

Authors:  Stefania Zanetti; Paola Molicotti; Sara Cannas; Silvia Ortu; Niyaz Ahmed; Leonardo A Sechi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-11-15       Impact factor: 3.944

6.  Sliding Motility, Biofilm Formation, and Glycopeptidolipid Production in Mycobacterium colombiense Strains.

Authors:  Milena Maya-Hoyos; John Leguizamón; Leonardo Mariño-Ramírez; Carlos Y Soto
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

7.  Treatment of refractory Crohn's disease and pyoderma gangrenosum with a combination regimen of rifaximin, gentamicin and metronidazole.

Authors:  Neil D Goldberg; Aravinda Vadlamudi; Nicole Parrish
Journal:  Case Rep Gastroenterol       Date:  2015-01-24

8.  Illegitimate recombination: an efficient method for random mutagenesis in Mycobacterium avium subsp. hominissuis.

Authors:  Faisal Asghar Khattak; Ashutosh Kumar; Elisabeth Kamal; Ralph Kunisch; Astrid Lewin
Journal:  BMC Microbiol       Date:  2012-09-11       Impact factor: 3.605

9.  The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease.

Authors:  Verlaine J Timms; George Daskalopoulos; Hazel M Mitchell; Brett A Neilan
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.